Skip to main content
Clinical Trials/KCT0003067
KCT0003067
Recruiting
未知

Safety and effectiveness of fluoroscopy-guided acupotomy for carpal tunnel syndrome; a randomized, patient-assessor blind, parallel clinical trial

Wonkwang University, Gwangju Medical Center0 sites38 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the musculo-skeletal system and connective tissue
Sponsor
Wonkwang University, Gwangju Medical Center
Enrollment
38
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Wonkwang University, Gwangju Medical Center

Eligibility Criteria

Inclusion Criteria

  • ? Male and female aged 20 to 69
  • ? Having numbness, tingling, nyctalgia symptom in the hand area with VAS over 5
  • ? Positive in Tinel’s sign or Phalen’s sign
  • ? Cross\-section area of medial nerve over 10mm2 measured by ultrasonography

Exclusion Criteria

  • ? Patients who had surgery for treating carpal tunnel syndrome.
  • ? Patients who has physical abnormality in carpal tunnel such as tumor or malunion.
  • ? Patients who are taking medicine related to mental disorder, immune disease, or diabetes.
  • ? Patients who are taking adrenocortical hormone or nonsteroidal inflammatory analgesic to treat carpal tunnel syndrome. In case of taking inflammatory analgesic, the patient has to stop taking the medicine 1 week prior to enroll in the study.
  • ? Patients who has skin allergy or skin infection.
  • ? Patients who are insulin\-treated diabetic patient, has cardiovascular disease or wearing a pacemaker, or has kindney disease.
  • ? Pregnant women, lactating women, who are positive in pregnancy test before random allocation, and who do not agree to use medically appropriate contraceptives (e.g., oral medication, hormone implants, intrauterine devices, condoms, or spermicides)
  • ? Patients deemed by a clinical research investigator to be inappropriate for participation in the clinical trial

Outcomes

Primary Outcomes

Not specified

Similar Trials